Intercure Ltd.
INCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857030
No open-market purchases or sales by Intercure Ltd. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $764.1K in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Intercure Ltd. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +3 vs. Q2 2022
- Shares held
- 4.85M
- −1.73M (−26.3%) vs. Q2 2022
- Total value
- $21.9M
- −$16.3M (−42.7%) vs. Q2 2022
- New holders
- 8
- 3 more added
- Sold out
- 5
- 6 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $764.1K |
| Q1 2026 | 15 | $617.9K |
| Q4 2025 | 18 | $796.3K |
| Q3 2025 | 22 | $3.44M |
| Q2 2025 | 19 | $3.68M |
| Q1 2025 | 15 | $3.50M |
| Q4 2024 | 17 | $4.00M |
| Q3 2024 | 20 | $5.22M |
| Q2 2024 | 19 | $6.04M |
| Q1 2024 | 17 | $8.92M |
| Q4 2023 | 18 | $4.93M |
| Q3 2023 | 20 | $5.43M |
| Q2 2023 | 19 | $5.30M |
| Q1 2023 | 18 | $8.29M |
| Q4 2022 | 15 | $9.75M |
| Q3 2022 | 21 | $21.9M |
| Q2 2022 | 18 | $38.1M |
| Q1 2022 | 19 | $34.8M |
| Q4 2021 | 23 | $26.9M |
| Q3 2021 | 16 | $16.3M |
| Q2 2021 | 2 | $5.37M |
| Q1 2021 | 1 | $8.38M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Intercure Ltd.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ibex Investors LLC | 1,886,274 | $8.49M | 7.20% | 00.0% | Unchanged |
| ETF Managers Group, LLC | 1,851,339 | $8.35M | 0.27% | −1,457,676−44.1% | Reduced |
| Mirae Asset Global Investments Co., Ltd. | 435,124 | $1.96M | 0.01% | −305,819−41.3% | Reduced |
| AdvisorShares Investments LLC | 223,190 | $1.01M | 0.27% | +46,184+26.1% | Added |
| Healthcare of Ontario Pension Plan Trust Fund | 212,500 | $961.0K | 0.00% | 00.0% | Unchanged |
| Cambria Investment Management, L.P. | 62,966 | $284.0K | 0.03% | +62,966 | New |
| Balyasny Asset Management LLC | 51,576 | $233.0K | 0.00% | +51,576 | New |
| ExodusPoint Capital Management, LP | 48,089 | $216.0K | 0.00% | +48,089 | New |
| Citadel Advisors LLC | 27,084 | $122.0K | 0.00% | +1,423+5.5% | Added |
| Geode Capital Management, LLC | 14,148 | $63.0K | 0.00% | +14,148 | New |
| BlackRock Inc. | 12,959 | $58.0K | 0.00% | +12,959 | New |
| Davy Global Fund Management Ltd | 11,723 | $53.0K | 0.01% | −10,550−47.4% | Reduced |
| UBS Group AG | 6,337 | $29.0K | 0.00% | +4,371+222.3% | Added |
| Morgan Stanley | 4,600 | $21.0K | 0.00% | −10.0% | Reduced |
| Tower Research Capital LLC (TRC) | 744 | $3.00K | 0.00% | −498−40.1% | Reduced |
| Bank of America Corp | 566 | $3.00K | 0.00% | +566 | New |
| Advisor Group Holdings, Inc. | 500 | $2.00K | 0.00% | 00.0% | Unchanged |
| Sugarloaf Wealth Management, LLC | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 71 | $0 | 0.00% | −6,238−98.9% | Reduced |
| Citigroup Inc | 36 | $0 | 0.00% | +36 | New |
| Royal Bank of Canada | 92 | $0 | 0.00% | +92 | New |
| Cohanzick Management, LLC | 0 | $0 | 0.00% | −128,525−100.0% | Sold out |
| RiverPark Advisors, LLC | 0 | $0 | 0.00% | −58,743−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −2,929−100.0% | Sold out |
| Banque Cantonale Vaudoise | 0 | $0 | 0.00% | −2,247−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −49−100.0% | Sold out |